Daijiworld Media Network - London
London, Nov 10: A breast cancer diagnosis can bring several difficult decisions, particularly for younger women who hope to become mothers in the future. While treatment and recovery remain the immediate priorities, concerns about fertility and the possibility of having children often arise.
However, a breast cancer diagnosis does not automatically mean the end of motherhood. The impact on fertility depends on several factors, including a woman's age, the type of cancer and the treatment involved.
Breast cancer itself does not directly damage the ovaries or reproductive organs. However, certain cancer treatments can affect reproductive health and reduce the chances of natural conception.
"Breast cancer does not necessarily mean the end of a woman's reproductive journey," explained Dr Mangala Devi KR, Consultant – Obstetrics and Gynaecology at Manipal Hospital, Old Airport Road.
Chemotherapy can damage ovarian follicles, which contain immature eggs. Depending on the medicines used and the woman's age, this may reduce ovarian reserve, cause temporary infertility or result in permanent loss of ovarian function. Some women may also experience premature menopause.
The impact of treatment varies from person to person. Younger women may have a better chance of recovering ovarian function, although age alone cannot predict the outcome.
Hormone therapy also requires careful pregnancy planning. Medicines such as tamoxifen and aromatase inhibitors are commonly prescribed for hormone-sensitive breast cancers. These drugs can affect menstrual cycles, and pregnancy is generally advised against while taking them.
Women who wish to have children in the future should discuss fertility preservation options with their doctors before beginning chemotherapy, wherever possible.
Dr Mangala Devi highlighted several available options, including egg freezing, in which unfertilised eggs are retrieved and frozen for future use, and embryo freezing, where retrieved eggs are fertilised with sperm before the resulting embryos are frozen.
Another option is ovarian tissue freezing, which involves removing and preserving a portion of ovarian tissue for potential future use. This may be considered in selected cases.
Women with hormone-sensitive breast cancer may also undergo specialised ovarian stimulation protocols using medicines such as letrozole to limit estrogen exposure.
Pregnancy may still be possible after breast cancer treatment. However, the appropriate timing depends on the cancer diagnosis, treatment received, risk of recurrence and the woman's reproductive health.
Women undergoing long-term hormone therapy should discuss their pregnancy plans well in advance. In selected cases, doctors may consider temporarily interrupting treatment under close medical supervision.
Stopping prescribed medication independently can compromise cancer treatment and should never be considered an option.
Dr Mangala Devi emphasised that fertility counselling should take place early, as discussions about future motherhood sometimes happen only after treatment decisions have already been made.
"Fertility preservation is about more than freezing eggs or embryos. It is about preserving choice, supporting quality of life and helping women make informed decisions about their future," she explained.
An early discussion involving an oncologist and fertility specialist can help women understand the available options without unnecessarily delaying cancer treatment.
The objective is not to guarantee motherhood, but to ensure that the possibility of having children in the future is not overlooked while planning cancer treatment.